This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
In a highly-anticipated biologic patent dispute, the US District Court for the District of New Jersey has found that Amgen's patents for Enbrel® (etanercept) are valid. Two ranked firms are involved in this dispute
